Therapy: Immunogenicity of Biologic Therapies-we Need Tolerance

Overview

Journal Nat Rev Rheumatol

Specialty Rheumatology

Date 2010 Oct 1

PMID 20882023

Citations 6

Authors

Charlotte L M Krieckaert

G Margret Bartelds

Gerrit-Jan Wolbink

Affiliations

Soon will be listed here.

Citing Articles

Assessing Immunogenicity in Drug Reviews and Prescribing Information in Japan.

Ishibai M, Kai M, Wakuda H, Oikawa I, Uemura N AAPS J. 2024; 26(6):109.

PMID: 39379741 DOI: 10.1208/s12248-024-00980-0.

Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies.

Kishimoto T Front Immunol. 2020; 11:969.

PMID: 32508839 PMC: 7251066. DOI: 10.3389/fimmu.2020.00969.

Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles.

Kishimoto T, Ferrari J, LaMothe R, Kolte P, Griset A, ONeil C Nat Nanotechnol. 2016; 11(10):890-899.

PMID: 27479756 DOI: 10.1038/nnano.2016.135.

Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response.

Talotta R, Berzi A, Atzeni F, Batticciotto A, Clerici M, Sarzi-Puttini P J Clin Immunol. 2015; 35(6):550-7.

PMID: 26271387 DOI: 10.1007/s10875-015-0182-0.

Cross-reactive and pre-existing antibodies to therapeutic antibodies--Effects on treatment and immunogenicity.

van Schie K, Wolbink G, Rispens T MAbs. 2015; 7(4):662-71.

PMID: 25962087 PMC: 4623040. DOI: 10.1080/19420862.2015.1048411.

References

Weinblatt M, Maddison P, Bulpitt K, Hazleman B, Urowitz M, Sturrock R . CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study. Arthritis Rheum. 1995; 38(11):1589-94. DOI: 10.1002/art.1780381110. View

Colombel J, Sandborn W, Reinisch W, Mantzaris G, Kornbluth A, Rachmilewitz D . Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010; 362(15):1383-95. DOI: 10.1056/NEJMoa0904492. View

Parker A, Zheng W, Griswold K, Bailey-Kellogg C . Optimization algorithms for functional deimmunization of therapeutic proteins. BMC Bioinformatics. 2010; 11:180. PMC: 2873530. DOI: 10.1186/1471-2105-11-180. View

Maini R, Breedveld F, Kalden J, Smolen J, Davis D, Macfarlane J . Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 1998; 41(9):1552-63. DOI: 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W. View

Coles A, Compston D, Selmaj K, Lake S, Moran S, Margolin D . Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med. 2008; 359(17):1786-801. DOI: 10.1056/NEJMoa0802670. View